
Biopôle to welcome three new buildings dedicated to life sciences by 2024
Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and laboratory space will
Greater Geneva Bern area Stories
Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and laboratory space will
With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the
ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of working even more
Using a special gas treatment, the Fribourg-based company Medistri suppresses all germs contained in the vials destined to receive the Covid-19 vaccine. The company expects
With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and
With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the
Researchers from EPFL have invented a technique to navigate electronic devices that are smaller than human hair inside blood vessels and reach arterioles. The next
With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzing a blood
Leading global biotech company CSL Behring has recently inaugurated a new state-of-the-art immunoglobulin manufacturing plant in the Swiss canton of Bern. In 2017, CSL Behring decided to
With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and
Valued at CHF 86 million and scheduled to be operational in 2024, the Pôle Santé campus aims to be a platform for the exchange of
A newly expanded, state-of-the-art facility will house both biologics manufacturer KBI Biopharma and cell line developer Selexis. Together, the two companies anticipate creating more than
The Swiss Integrative Center for Human Health (SICHH) and EIKON, Fribourg’s Vocational School of Applied Arts, have launched a new scientific communication platform called “Connect
Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The new YpsoMate Zero uses alternative biopolymers and a novel packaging design that follows
Lonza’s new building dedicated to the manufacturing of Moderna’s Covid-19 vaccine will be operational starting December 2020. 300 million doses will be produced annually at
Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a focus
Rheon Medical is revolutionizing glaucoma treatment with its eyeWatch system, in which Coat-X’s coating technology plays a central role. Both start-ups were awarded prizes at
CERN and Lausanne University Hospital (CHUV) are collaborating to develop the conceptual design of an innovative radiotherapy facility used for cancer treatment. CERN, in the
The Immunology and Allergy Department of Lausanne University Hospital has received European funding of nearly CHF 5 million for its research aimed at identifying antibodies
Lonza will expand its production infrastructure in the canton of Valais with the construction of a sixth production line at its Biopark in Visp, thereby
The glass slides used to prepare samples for looking at under a microscope have hardly changed in the nearly 200 years since their invention. Breaking
U.S. biopharma Incyte has inaugurated its new European headquarters in Morges on July 6th. In parallel, the company is investing 100 million Swiss francs in
ORamaVR, a deep technology company specializing in virtual reality (VR) innovations for medical and surgical hands-on training, has moved its headquarters to Geneva. Lonza announced
Open to both research and industry, the new BSL-3 biosafety laboratory at the University of Bern Institute of Infectious Diseases can be used by external
A recent innovation from the EPFL Laboratory of Stem Cell Bioengineering will enable the mass production of standardized organoids for the first time. This scalable
Swiss start-up Adamant Innotech and CSEM are developing a rapid serological test to determine if a person has been previously infected with the SARS‐CoV‐2 virus
EPFL students have teamed up with start-up IcosaMed to develop the SmartBra, the first piece of smart clothing that can be used for cancer prevention.
The most sought after product in the midst of the COVID-19 pandemic is a Swiss invention. The hydro-alcoholic gel was formulated in the 1970s by
A team of researchers from the University of Fribourg has shown that the analysis of the microbial flora present in the saliva enables the early
The Idiap research institute now hosts a bioinformatics research group focusing on amyotrophic lateral sclerosis. Known above all for its advances in the fields
HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.
PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.
CONTACT
Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.
2021 © PharmaBoardroom